BCN-PEG3-VC-PFP ester
BCN-PEG3-VC-PFP ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) [1]. BCN-PEG3-VC-PFP ester is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Product Specifications
CAS Number
2353409-45-5
UNSPSC
12352203
Hazard Statement
H302-H315-H319-H335
Target
ADC Linker
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcn-peg3-vc-pfp-ester.html
Solubility
10 mM in DMSO
Smiles
O=C(NCCOCCOCCOCCC(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=O)C(OC(C(F)=C(F)C(F)=C1F)=C1F)=O)=O)=O)OC[C@@H]2[C@@]3([H])[C@]2([H])CCC#CCC3
Molecular Formula
C37H50F5N5O10
Molecular Weight
819.81
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16 (5) :315-337.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
Cleavable Linker; Protease Cleavable Linker
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CA 19-9 (Cancer, Cancer antigen 19-9, CA 199) (MaxLight 550)
Lentiviral human KCNC1 shRNA (UAS) - Lentiviral human KCNC1 shRNA (UAS, GFP) (100)
